U.S. Markets closed

Chesco biopharm firm cuts 21 jobs as part of restructuring

John George
American City Business Journals

Chester County biopharmaceutical company Trevena Inc. is cutting 21 jobs and halting its investments in early-stage research under a restructuring to focus its resources on its lead new drug candidate. The workforce reduction represents 30 percent of the Chesterbook, Pa., company's staff. Trevena's immediate focus will be on the potential approval and commercialization of Olinvo, its new drug candidate under development as a potential treatment to manage moderate-to-severe acute pain.